{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:20:25Z","timestamp":1773156025524,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.05.048","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T08:31:54Z","timestamp":1244017914000},"page":"4412-4423","source":"Crossref","is-referenced-by-count":130,"title":["Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Ronggai","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir A.W.","family":"Skeiky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerabadran","family":"Dheenadhayalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria","family":"Imam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Penn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Stagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fulkerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Scanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Hone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus A.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan H.E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald C.","family":"Sadoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.05.048_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2004.02609.x","article-title":"In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis","volume":"138","author":"Al-Attiyah","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib2","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.71.8.4271-4277.2003","article-title":"Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs","volume":"71","author":"Allen","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib3","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib5","first-page":"438","article-title":"Tuberculosis: a global emergency","volume":"14","author":"Anon.","year":"1993","journal-title":"World Health Forum"},{"key":"10.1016\/j.vaccine.2009.05.048_bib6","first-page":"810","article-title":"WHO and UNAIDS call for joint HIV-tuberculosis action","volume":"82","author":"Anon.","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.05.048_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01624546","article-title":"WHO declares tuberculosis a global emergency","volume":"38","author":"Anon.","year":"1993","journal-title":"Soz Praventivmed"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2009.05.048_bib8","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1086\/430786","article-title":"The World Health Organization\/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases","volume":"41","author":"Aziz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.iy.09.040191.001543","article-title":"The SCID mouse mutant: definition, characterization, and potential uses","volume":"9","author":"Bosma","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib10","first-page":"203","article-title":"Infectious lung complications in patients with HIV\/AIDS","volume":"11","author":"Boyton","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib11","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/dna.2006.25.438","article-title":"A combined DNA vaccine-prime. BCG-boost strategy results in better protection against Mycobacterium bovis challenge","volume":"25","author":"Cai","year":"2006","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib13","first-page":"1072","article-title":"Tuberculosis epidemiology in India: a review","volume":"9","author":"Chadha","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib14","first-page":"477","article-title":"Tuberculosis in children with human immunodeficiency virus infection","volume":"9","author":"Chintu","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.05.048_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib17","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.70.1.292-302.2002","article-title":"DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis","volume":"70","author":"Delogu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1128\/IAI.72.3.1685-1692.2004","article-title":"Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis","volume":"72","author":"Derrick","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib20","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib21","first-page":"213","article-title":"Global tuberculosis incidence and mortality during 1990\u20132000","volume":"72","author":"Dolin","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.05.048_bib22","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"Dye","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib23","unstructured":"Fine PEM, Carneiro IAM, Milstien JB, Clements CJ. Issues relating to the use of BCG in immunization programs. World Health Organization, vol. WHO\/V&B\/99.23. 1999."},{"key":"10.1016\/j.vaccine.2009.05.048_bib24","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib25","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1096\/fj.02-0533fje","article-title":"Genotype and age influence the effect of caloric intake on mortality in mice","volume":"17","author":"Forster","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2009.05.048_bib27","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.4049\/jimmunol.165.11.6463","article-title":"Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans","volume":"165","author":"Geluk","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3201\/eid0805.020002","article-title":"Worldwide occurrence of Beijing\/W strains of Mycobacterium tuberculosis: a systematic review","volume":"8","author":"Glynn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib29","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2009.05.048_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib31","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib32","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI31947","article-title":"Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis","volume":"117","author":"Hinchey","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2009.05.048_bib33","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.05.048_bib34","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1093\/clind\/15.Supplement_1.S296","article-title":"Evaluation of new anti-infective drugs for the treatment and prevention of infections caused by the Mycobacterium avium complex. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"Hopewell","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib36","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1128\/IAI.73.8.4676-4683.2005","article-title":"Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein","volume":"73","author":"Horwitz","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib37","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib38","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1365-2958.1996.00074.x","article-title":"Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen","volume":"21","author":"Jones","year":"1996","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/7701","article-title":"A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection","volume":"21","author":"Jouanguy","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2009.05.048_bib42","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development","volume":"23","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.048_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35095558","article-title":"How can immunology contribute to the control of tuberculosis?","volume":"1","author":"Kaufmann","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/eji.200425332","article-title":"The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses","volume":"35","author":"Korf","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib45","series-title":"Tuberculosis and the tubercle bacillus","first-page":"71","article-title":"Immune-based methods","author":"Laal","year":"2005"},{"key":"10.1016\/j.vaccine.2009.05.048_bib46","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.05.048_bib47","first-page":"256","article-title":"Transformation of BCG with plasmid DNA","volume":"7","author":"Lugosi","year":"1989","journal-title":"Acta Leprol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib48","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-3156.2005.01456.x","article-title":"Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies","volume":"10","author":"Maher","year":"2005","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2009.05.048_bib49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccm.2005.02.009","article-title":"Global epidemiology of tuberculosis","volume":"26","author":"Maher","year":"2005","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib50","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha\/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.048_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2009.05.048_bib52","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2009.05.048_bib53","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/IAI.68.7.3933-3940.2000","article-title":"Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines","volume":"68","author":"Mustafa","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","article-title":"Immunity to tuberculosis","volume":"22","author":"North","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib55","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A","article-title":"Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen","volume":"30","author":"Olsen","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib56","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib57","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/IAI.60.11.4781-4792.1992","article-title":"Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis","volume":"60","author":"Pal","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib58","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/IAI.60.7.2710-2717.1992","article-title":"Capacity of listeriolysin O, streptolysin O, and perfringolysin O to mediate growth of Bacillus subtilis within mammalian cells","volume":"60","author":"Portnoy","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib59","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib60","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib61","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1016\/j.vaccine.2005.03.003","article-title":"Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41","volume":"23","author":"Skeiky","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.048_bib62","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib63","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib64","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib65","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"Skjot","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib66","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1128\/IAI.68.12.7144-7148.2000","article-title":"Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia","volume":"68","author":"Smith","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib67","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/IAI.65.11.4515-4524.1997","article-title":"Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry","volume":"65","author":"Sonnenberg","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib68","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2009.05.048_bib69","first-page":"149","article-title":"Tuberculosis: a global overview of the situation today","volume":"70","author":"Sudre","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.05.048_bib70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1517\/14656566.5.3.581","article-title":"The use of TNF-alpha blocking agents in rheumatoid arthritis: an overview","volume":"5","author":"Toussirot","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.vaccine.2009.05.048_bib71","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A replication-limited recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib72","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2009.05.048_bib73","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Weinrich-Olsen","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.048_bib74","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1128\/IAI.66.8.3492-3500.1998","article-title":"Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins","volume":"66","author":"Weldingh","year":"1998","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T12:37:18Z","timestamp":1685018238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09007610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":74,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09007610"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}